ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.785
      0.00%
      Bitcoin
      64,831.33
      -0.47%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Mast Therapeutics, Inc. (ANX)

      7. Mast Therapeutics, Inc. (ANX) News

      ANX

      Adventrx (ANX)

      Mast Therapeutics, Inc.
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:ANX
      DateTimeSourceHeadlineSymbolCompany
      05/21/20124:35PMEdgar (US Regulatory)Current report filing (8-K)AMEX:ANXMast Therapeutics, Inc.
      05/14/20128:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
      05/10/20128:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
      05/07/20124:40PMEdgar (US Regulatory)Quarterly Report (10-Q)AMEX:ANXMast Therapeutics, Inc.
      05/07/201210:58AMEdgar (US Regulatory)Current report filing (8-K)AMEX:ANXMast Therapeutics, Inc.
      05/07/20128:00AMPR Newswire (US)ADVENTRX Reports First Quarter 2012 Financial ResultsAMEX:ANXMast Therapeutics, Inc.
      05/02/20126:04AMEdgar (US Regulatory)Notice of Effectiveness (EFFECT)AMEX:ANXMast Therapeutics, Inc.
      04/27/20129:04AMEdgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)AMEX:ANXMast Therapeutics, Inc.
      04/16/20128:00AMPR Newswire (US)ADVENTRX Pharmaceuticals to Sponsor & Present at the Martin Center's 2012 Sickle Cell Disease ConferenceAMEX:ANXMast Therapeutics, Inc.
      04/09/20128:00AMPR Newswire (US)ADVENTRX Announces Establishment of Regulatory Advisory BoardAMEX:ANXMast Therapeutics, Inc.
      04/04/20126:04AMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:ANXMast Therapeutics, Inc.
      03/21/20129:15AMPR Newswire (US)Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; $3.50 Target PriceAMEX:ANXMast Therapeutics, Inc.
      03/15/20124:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
      03/15/20128:00AMPR Newswire (US)ADVENTRX CEO Selected by Combined Health Agencies as a 2012 Health HeroAMEX:ANXMast Therapeutics, Inc.
      03/14/20124:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
      03/08/20124:35PMEdgar (US Regulatory)Securities Registration Statement (simplified form) (S-3)AMEX:ANXMast Therapeutics, Inc.
      03/08/20124:12PMEdgar (US Regulatory)Amended Current report filing (8-K/A)AMEX:ANXMast Therapeutics, Inc.
      03/08/20124:11PMEdgar (US Regulatory)Annual Report (10-K)AMEX:ANXMast Therapeutics, Inc.
      03/07/20125:15PMEdgar (US Regulatory)Current report filing (8-K)AMEX:ANXMast Therapeutics, Inc.
      03/07/20124:30PMPR Newswire (US)ADVENTRX Reports Fourth Quarter and Full Year 2011 Financial ResultsAMEX:ANXMast Therapeutics, Inc.
      02/27/20124:14PMEdgar (US Regulatory)Current report filing (8-K)AMEX:ANXMast Therapeutics, Inc.
      02/23/20128:20AMMarketwiredBiotech Investments on the Upswing - Keryx and ADVENTRX Poised to BenefitAMEX:ANXMast Therapeutics, Inc.
      02/14/20125:16PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:ANXMast Therapeutics, Inc.
      02/07/20128:00AMPR Newswire (US)ADVENTRX Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference on February 14AMEX:ANXMast Therapeutics, Inc.
      02/02/20129:15AMPR Newswire (US)Vista Partners Publishes February 2012 NewsletterAMEX:ANXMast Therapeutics, Inc.
      01/31/20128:20AMMarketwiredBiotech Sector on the Upswing -- Dendreon and ADVENTRX Pharmaceuticals Looking StrongAMEX:ANXMast Therapeutics, Inc.
      01/23/20124:33PMEdgar (US Regulatory)Current report filing (8-K)AMEX:ANXMast Therapeutics, Inc.
      12/19/20118:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
      12/19/20113:14AMZacksZacks #1 Rank Additions for Monday - Tale of the TapeAMEX:ANXMast Therapeutics, Inc.
      12/15/20119:15AMPR Newswire (US)Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; $3.50 Target PriceAMEX:ANXMast Therapeutics, Inc.
       Showing the most relevant articles for your search:AMEX:ANX